Global Patent Drug Market Research Report 2024(Status and Outlook)
Report Overview
A patent medicine is typically protected and advertised by a trademark and trade name (and sometimes a patent) and claimed to be effective against minor disorders and symptoms.
This report provides a deep insight into the global Patent Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Patent Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Patent Drug market in any manner.
Global Patent Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
AbbVie
Takeda
Boehringer Ingelheim
Takeda
Market Segmentation (by Type)
Oral
Injection
Other
Market Segmentation (by Application)
Hospital
Retail Pharmacy
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Patent Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
A patent medicine is typically protected and advertised by a trademark and trade name (and sometimes a patent) and claimed to be effective against minor disorders and symptoms.
This report provides a deep insight into the global Patent Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Patent Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Patent Drug market in any manner.
Global Patent Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
AbbVie
Takeda
Boehringer Ingelheim
Takeda
Market Segmentation (by Type)
Oral
Injection
Other
Market Segmentation (by Application)
Hospital
Retail Pharmacy
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Patent Drug Market
- Overview of the regional outlook of the Patent Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Patent Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Patent Drug
1.2 Key Market Segments
1.2.1 Patent Drug Segment by Type
1.2.2 Patent Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PATENT DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Patent Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Patent Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PATENT DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Patent Drug Sales by Manufacturers (2019-2024)
3.2 Global Patent Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Patent Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Patent Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Patent Drug Sales Sites, Area Served, Product Type
3.6 Patent Drug Market Competitive Situation and Trends
3.6.1 Patent Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Patent Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PATENT DRUG INDUSTRY CHAIN ANALYSIS
4.1 Patent Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PATENT DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PATENT DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Patent Drug Sales Market Share by Type (2019-2024)
6.3 Global Patent Drug Market Size Market Share by Type (2019-2024)
6.4 Global Patent Drug Price by Type (2019-2024)
7 PATENT DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Patent Drug Market Sales by Application (2019-2024)
7.3 Global Patent Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Patent Drug Sales Growth Rate by Application (2019-2024)
8 PATENT DRUG MARKET SEGMENTATION BY REGION
8.1 Global Patent Drug Sales by Region
8.1.1 Global Patent Drug Sales by Region
8.1.2 Global Patent Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Patent Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Patent Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Patent Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Patent Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Patent Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Patent Drug Basic Information
9.1.2 Pfizer Patent Drug Product Overview
9.1.3 Pfizer Patent Drug Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Patent Drug SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Roche
9.2.1 Roche Patent Drug Basic Information
9.2.2 Roche Patent Drug Product Overview
9.2.3 Roche Patent Drug Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche Patent Drug SWOT Analysis
9.2.6 Roche Recent Developments
9.3 Sanofi
9.3.1 Sanofi Patent Drug Basic Information
9.3.2 Sanofi Patent Drug Product Overview
9.3.3 Sanofi Patent Drug Product Market Performance
9.3.4 Sanofi Patent Drug SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Johnson and Johnson
9.4.1 Johnson and Johnson Patent Drug Basic Information
9.4.2 Johnson and Johnson Patent Drug Product Overview
9.4.3 Johnson and Johnson Patent Drug Product Market Performance
9.4.4 Johnson and Johnson Business Overview
9.4.5 Johnson and Johnson Recent Developments
9.5 Merck and Co. (MSD)
9.5.1 Merck and Co. (MSD) Patent Drug Basic Information
9.5.2 Merck and Co. (MSD) Patent Drug Product Overview
9.5.3 Merck and Co. (MSD) Patent Drug Product Market Performance
9.5.4 Merck and Co. (MSD) Business Overview
9.5.5 Merck and Co. (MSD) Recent Developments
9.6 Novartis
9.6.1 Novartis Patent Drug Basic Information
9.6.2 Novartis Patent Drug Product Overview
9.6.3 Novartis Patent Drug Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 AbbVie
9.7.1 AbbVie Patent Drug Basic Information
9.7.2 AbbVie Patent Drug Product Overview
9.7.3 AbbVie Patent Drug Product Market Performance
9.7.4 AbbVie Business Overview
9.7.5 AbbVie Recent Developments
9.8 Gilead Sciences
9.8.1 Gilead Sciences Patent Drug Basic Information
9.8.2 Gilead Sciences Patent Drug Product Overview
9.8.3 Gilead Sciences Patent Drug Product Market Performance
9.8.4 Gilead Sciences Business Overview
9.8.5 Gilead Sciences Recent Developments
9.9 GlaxoSmithKline (GSK)
9.9.1 GlaxoSmithKline (GSK) Patent Drug Basic Information
9.9.2 GlaxoSmithKline (GSK) Patent Drug Product Overview
9.9.3 GlaxoSmithKline (GSK) Patent Drug Product Market Performance
9.9.4 GlaxoSmithKline (GSK) Business Overview
9.9.5 GlaxoSmithKline (GSK) Recent Developments
9.10 Amgen
9.10.1 Amgen Patent Drug Basic Information
9.10.2 Amgen Patent Drug Product Overview
9.10.3 Amgen Patent Drug Product Market Performance
9.10.4 Amgen Business Overview
9.10.5 Amgen Recent Developments
9.11 AstraZeneca
9.11.1 AstraZeneca Patent Drug Basic Information
9.11.2 AstraZeneca Patent Drug Product Overview
9.11.3 AstraZeneca Patent Drug Product Market Performance
9.11.4 AstraZeneca Business Overview
9.11.5 AstraZeneca Recent Developments
9.12 Bristol-Myers Squibb
9.12.1 Bristol-Myers Squibb Patent Drug Basic Information
9.12.2 Bristol-Myers Squibb Patent Drug Product Overview
9.12.3 Bristol-Myers Squibb Patent Drug Product Market Performance
9.12.4 Bristol-Myers Squibb Business Overview
9.12.5 Bristol-Myers Squibb Recent Developments
9.13 Eli Lilly
9.13.1 Eli Lilly Patent Drug Basic Information
9.13.2 Eli Lilly Patent Drug Product Overview
9.13.3 Eli Lilly Patent Drug Product Market Performance
9.13.4 Eli Lilly Business Overview
9.13.5 Eli Lilly Recent Developments
9.14 Teva
9.14.1 Teva Patent Drug Basic Information
9.14.2 Teva Patent Drug Product Overview
9.14.3 Teva Patent Drug Product Market Performance
9.14.4 Teva Business Overview
9.14.5 Teva Recent Developments
9.15 Bayer
9.15.1 Bayer Patent Drug Basic Information
9.15.2 Bayer Patent Drug Product Overview
9.15.3 Bayer Patent Drug Product Market Performance
9.15.4 Bayer Business Overview
9.15.5 Bayer Recent Developments
9.16 Novo Nordisk
9.16.1 Novo Nordisk Patent Drug Basic Information
9.16.2 Novo Nordisk Patent Drug Product Overview
9.16.3 Novo Nordisk Patent Drug Product Market Performance
9.16.4 Novo Nordisk Business Overview
9.16.5 Novo Nordisk Recent Developments
9.17 AbbVie
9.17.1 AbbVie Patent Drug Basic Information
9.17.2 AbbVie Patent Drug Product Overview
9.17.3 AbbVie Patent Drug Product Market Performance
9.17.4 AbbVie Business Overview
9.17.5 AbbVie Recent Developments
9.18 Takeda
9.18.1 Takeda Patent Drug Basic Information
9.18.2 Takeda Patent Drug Product Overview
9.18.3 Takeda Patent Drug Product Market Performance
9.18.4 Takeda Business Overview
9.18.5 Takeda Recent Developments
9.19 Boehringer Ingelheim
9.19.1 Boehringer Ingelheim Patent Drug Basic Information
9.19.2 Boehringer Ingelheim Patent Drug Product Overview
9.19.3 Boehringer Ingelheim Patent Drug Product Market Performance
9.19.4 Boehringer Ingelheim Business Overview
9.19.5 Boehringer Ingelheim Recent Developments
9.20 Takeda
9.20.1 Takeda Patent Drug Basic Information
9.20.2 Takeda Patent Drug Product Overview
9.20.3 Takeda Patent Drug Product Market Performance
9.20.4 Takeda Business Overview
9.20.5 Takeda Recent Developments
10 PATENT DRUG MARKET FORECAST BY REGION
10.1 Global Patent Drug Market Size Forecast
10.2 Global Patent Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Patent Drug Market Size Forecast by Country
10.2.3 Asia Pacific Patent Drug Market Size Forecast by Region
10.2.4 South America Patent Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Patent Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Patent Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Patent Drug by Type (2025-2030)
11.1.2 Global Patent Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Patent Drug by Type (2025-2030)
11.2 Global Patent Drug Market Forecast by Application (2025-2030)
11.2.1 Global Patent Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Patent Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Patent Drug
1.2 Key Market Segments
1.2.1 Patent Drug Segment by Type
1.2.2 Patent Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PATENT DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Patent Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Patent Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PATENT DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Patent Drug Sales by Manufacturers (2019-2024)
3.2 Global Patent Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Patent Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Patent Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Patent Drug Sales Sites, Area Served, Product Type
3.6 Patent Drug Market Competitive Situation and Trends
3.6.1 Patent Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Patent Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PATENT DRUG INDUSTRY CHAIN ANALYSIS
4.1 Patent Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PATENT DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PATENT DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Patent Drug Sales Market Share by Type (2019-2024)
6.3 Global Patent Drug Market Size Market Share by Type (2019-2024)
6.4 Global Patent Drug Price by Type (2019-2024)
7 PATENT DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Patent Drug Market Sales by Application (2019-2024)
7.3 Global Patent Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Patent Drug Sales Growth Rate by Application (2019-2024)
8 PATENT DRUG MARKET SEGMENTATION BY REGION
8.1 Global Patent Drug Sales by Region
8.1.1 Global Patent Drug Sales by Region
8.1.2 Global Patent Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Patent Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Patent Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Patent Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Patent Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Patent Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Patent Drug Basic Information
9.1.2 Pfizer Patent Drug Product Overview
9.1.3 Pfizer Patent Drug Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Patent Drug SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 Roche
9.2.1 Roche Patent Drug Basic Information
9.2.2 Roche Patent Drug Product Overview
9.2.3 Roche Patent Drug Product Market Performance
9.2.4 Roche Business Overview
9.2.5 Roche Patent Drug SWOT Analysis
9.2.6 Roche Recent Developments
9.3 Sanofi
9.3.1 Sanofi Patent Drug Basic Information
9.3.2 Sanofi Patent Drug Product Overview
9.3.3 Sanofi Patent Drug Product Market Performance
9.3.4 Sanofi Patent Drug SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Johnson and Johnson
9.4.1 Johnson and Johnson Patent Drug Basic Information
9.4.2 Johnson and Johnson Patent Drug Product Overview
9.4.3 Johnson and Johnson Patent Drug Product Market Performance
9.4.4 Johnson and Johnson Business Overview
9.4.5 Johnson and Johnson Recent Developments
9.5 Merck and Co. (MSD)
9.5.1 Merck and Co. (MSD) Patent Drug Basic Information
9.5.2 Merck and Co. (MSD) Patent Drug Product Overview
9.5.3 Merck and Co. (MSD) Patent Drug Product Market Performance
9.5.4 Merck and Co. (MSD) Business Overview
9.5.5 Merck and Co. (MSD) Recent Developments
9.6 Novartis
9.6.1 Novartis Patent Drug Basic Information
9.6.2 Novartis Patent Drug Product Overview
9.6.3 Novartis Patent Drug Product Market Performance
9.6.4 Novartis Business Overview
9.6.5 Novartis Recent Developments
9.7 AbbVie
9.7.1 AbbVie Patent Drug Basic Information
9.7.2 AbbVie Patent Drug Product Overview
9.7.3 AbbVie Patent Drug Product Market Performance
9.7.4 AbbVie Business Overview
9.7.5 AbbVie Recent Developments
9.8 Gilead Sciences
9.8.1 Gilead Sciences Patent Drug Basic Information
9.8.2 Gilead Sciences Patent Drug Product Overview
9.8.3 Gilead Sciences Patent Drug Product Market Performance
9.8.4 Gilead Sciences Business Overview
9.8.5 Gilead Sciences Recent Developments
9.9 GlaxoSmithKline (GSK)
9.9.1 GlaxoSmithKline (GSK) Patent Drug Basic Information
9.9.2 GlaxoSmithKline (GSK) Patent Drug Product Overview
9.9.3 GlaxoSmithKline (GSK) Patent Drug Product Market Performance
9.9.4 GlaxoSmithKline (GSK) Business Overview
9.9.5 GlaxoSmithKline (GSK) Recent Developments
9.10 Amgen
9.10.1 Amgen Patent Drug Basic Information
9.10.2 Amgen Patent Drug Product Overview
9.10.3 Amgen Patent Drug Product Market Performance
9.10.4 Amgen Business Overview
9.10.5 Amgen Recent Developments
9.11 AstraZeneca
9.11.1 AstraZeneca Patent Drug Basic Information
9.11.2 AstraZeneca Patent Drug Product Overview
9.11.3 AstraZeneca Patent Drug Product Market Performance
9.11.4 AstraZeneca Business Overview
9.11.5 AstraZeneca Recent Developments
9.12 Bristol-Myers Squibb
9.12.1 Bristol-Myers Squibb Patent Drug Basic Information
9.12.2 Bristol-Myers Squibb Patent Drug Product Overview
9.12.3 Bristol-Myers Squibb Patent Drug Product Market Performance
9.12.4 Bristol-Myers Squibb Business Overview
9.12.5 Bristol-Myers Squibb Recent Developments
9.13 Eli Lilly
9.13.1 Eli Lilly Patent Drug Basic Information
9.13.2 Eli Lilly Patent Drug Product Overview
9.13.3 Eli Lilly Patent Drug Product Market Performance
9.13.4 Eli Lilly Business Overview
9.13.5 Eli Lilly Recent Developments
9.14 Teva
9.14.1 Teva Patent Drug Basic Information
9.14.2 Teva Patent Drug Product Overview
9.14.3 Teva Patent Drug Product Market Performance
9.14.4 Teva Business Overview
9.14.5 Teva Recent Developments
9.15 Bayer
9.15.1 Bayer Patent Drug Basic Information
9.15.2 Bayer Patent Drug Product Overview
9.15.3 Bayer Patent Drug Product Market Performance
9.15.4 Bayer Business Overview
9.15.5 Bayer Recent Developments
9.16 Novo Nordisk
9.16.1 Novo Nordisk Patent Drug Basic Information
9.16.2 Novo Nordisk Patent Drug Product Overview
9.16.3 Novo Nordisk Patent Drug Product Market Performance
9.16.4 Novo Nordisk Business Overview
9.16.5 Novo Nordisk Recent Developments
9.17 AbbVie
9.17.1 AbbVie Patent Drug Basic Information
9.17.2 AbbVie Patent Drug Product Overview
9.17.3 AbbVie Patent Drug Product Market Performance
9.17.4 AbbVie Business Overview
9.17.5 AbbVie Recent Developments
9.18 Takeda
9.18.1 Takeda Patent Drug Basic Information
9.18.2 Takeda Patent Drug Product Overview
9.18.3 Takeda Patent Drug Product Market Performance
9.18.4 Takeda Business Overview
9.18.5 Takeda Recent Developments
9.19 Boehringer Ingelheim
9.19.1 Boehringer Ingelheim Patent Drug Basic Information
9.19.2 Boehringer Ingelheim Patent Drug Product Overview
9.19.3 Boehringer Ingelheim Patent Drug Product Market Performance
9.19.4 Boehringer Ingelheim Business Overview
9.19.5 Boehringer Ingelheim Recent Developments
9.20 Takeda
9.20.1 Takeda Patent Drug Basic Information
9.20.2 Takeda Patent Drug Product Overview
9.20.3 Takeda Patent Drug Product Market Performance
9.20.4 Takeda Business Overview
9.20.5 Takeda Recent Developments
10 PATENT DRUG MARKET FORECAST BY REGION
10.1 Global Patent Drug Market Size Forecast
10.2 Global Patent Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Patent Drug Market Size Forecast by Country
10.2.3 Asia Pacific Patent Drug Market Size Forecast by Region
10.2.4 South America Patent Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Patent Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Patent Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Patent Drug by Type (2025-2030)
11.1.2 Global Patent Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Patent Drug by Type (2025-2030)
11.2 Global Patent Drug Market Forecast by Application (2025-2030)
11.2.1 Global Patent Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Patent Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Patent Drug Market Size Comparison by Region (M USD)
Table 5. Global Patent Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Patent Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Patent Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Patent Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Drug as of 2022)
Table 10. Global Market Patent Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Patent Drug Sales Sites and Area Served
Table 12. Manufacturers Patent Drug Product Type
Table 13. Global Patent Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Patent Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Patent Drug Market Challenges
Table 22. Global Patent Drug Sales by Type (Kilotons)
Table 23. Global Patent Drug Market Size by Type (M USD)
Table 24. Global Patent Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Patent Drug Sales Market Share by Type (2019-2024)
Table 26. Global Patent Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Patent Drug Market Size Share by Type (2019-2024)
Table 28. Global Patent Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Patent Drug Sales (Kilotons) by Application
Table 30. Global Patent Drug Market Size by Application
Table 31. Global Patent Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Patent Drug Sales Market Share by Application (2019-2024)
Table 33. Global Patent Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Patent Drug Market Share by Application (2019-2024)
Table 35. Global Patent Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Patent Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Patent Drug Sales Market Share by Region (2019-2024)
Table 38. North America Patent Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Patent Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Patent Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Patent Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Patent Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Patent Drug Basic Information
Table 44. Pfizer Patent Drug Product Overview
Table 45. Pfizer Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Patent Drug SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Roche Patent Drug Basic Information
Table 50. Roche Patent Drug Product Overview
Table 51. Roche Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Roche Business Overview
Table 53. Roche Patent Drug SWOT Analysis
Table 54. Roche Recent Developments
Table 55. Sanofi Patent Drug Basic Information
Table 56. Sanofi Patent Drug Product Overview
Table 57. Sanofi Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Patent Drug SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Johnson and Johnson Patent Drug Basic Information
Table 62. Johnson and Johnson Patent Drug Product Overview
Table 63. Johnson and Johnson Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Johnson and Johnson Business Overview
Table 65. Johnson and Johnson Recent Developments
Table 66. Merck and Co. (MSD) Patent Drug Basic Information
Table 67. Merck and Co. (MSD) Patent Drug Product Overview
Table 68. Merck and Co. (MSD) Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Merck and Co. (MSD) Business Overview
Table 70. Merck and Co. (MSD) Recent Developments
Table 71. Novartis Patent Drug Basic Information
Table 72. Novartis Patent Drug Product Overview
Table 73. Novartis Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. AbbVie Patent Drug Basic Information
Table 77. AbbVie Patent Drug Product Overview
Table 78. AbbVie Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. AbbVie Business Overview
Table 80. AbbVie Recent Developments
Table 81. Gilead Sciences Patent Drug Basic Information
Table 82. Gilead Sciences Patent Drug Product Overview
Table 83. Gilead Sciences Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Gilead Sciences Business Overview
Table 85. Gilead Sciences Recent Developments
Table 86. GlaxoSmithKline (GSK) Patent Drug Basic Information
Table 87. GlaxoSmithKline (GSK) Patent Drug Product Overview
Table 88. GlaxoSmithKline (GSK) Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. GlaxoSmithKline (GSK) Business Overview
Table 90. GlaxoSmithKline (GSK) Recent Developments
Table 91. Amgen Patent Drug Basic Information
Table 92. Amgen Patent Drug Product Overview
Table 93. Amgen Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Amgen Business Overview
Table 95. Amgen Recent Developments
Table 96. AstraZeneca Patent Drug Basic Information
Table 97. AstraZeneca Patent Drug Product Overview
Table 98. AstraZeneca Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. AstraZeneca Business Overview
Table 100. AstraZeneca Recent Developments
Table 101. Bristol-Myers Squibb Patent Drug Basic Information
Table 102. Bristol-Myers Squibb Patent Drug Product Overview
Table 103. Bristol-Myers Squibb Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Bristol-Myers Squibb Business Overview
Table 105. Bristol-Myers Squibb Recent Developments
Table 106. Eli Lilly Patent Drug Basic Information
Table 107. Eli Lilly Patent Drug Product Overview
Table 108. Eli Lilly Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Eli Lilly Business Overview
Table 110. Eli Lilly Recent Developments
Table 111. Teva Patent Drug Basic Information
Table 112. Teva Patent Drug Product Overview
Table 113. Teva Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Teva Business Overview
Table 115. Teva Recent Developments
Table 116. Bayer Patent Drug Basic Information
Table 117. Bayer Patent Drug Product Overview
Table 118. Bayer Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Bayer Business Overview
Table 120. Bayer Recent Developments
Table 121. Novo Nordisk Patent Drug Basic Information
Table 122. Novo Nordisk Patent Drug Product Overview
Table 123. Novo Nordisk Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Novo Nordisk Business Overview
Table 125. Novo Nordisk Recent Developments
Table 126. AbbVie Patent Drug Basic Information
Table 127. AbbVie Patent Drug Product Overview
Table 128. AbbVie Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. AbbVie Business Overview
Table 130. AbbVie Recent Developments
Table 131. Takeda Patent Drug Basic Information
Table 132. Takeda Patent Drug Product Overview
Table 133. Takeda Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Takeda Business Overview
Table 135. Takeda Recent Developments
Table 136. Boehringer Ingelheim Patent Drug Basic Information
Table 137. Boehringer Ingelheim Patent Drug Product Overview
Table 138. Boehringer Ingelheim Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Boehringer Ingelheim Business Overview
Table 140. Boehringer Ingelheim Recent Developments
Table 141. Takeda Patent Drug Basic Information
Table 142. Takeda Patent Drug Product Overview
Table 143. Takeda Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Takeda Business Overview
Table 145. Takeda Recent Developments
Table 146. Global Patent Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 147. Global Patent Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Patent Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 149. North America Patent Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Patent Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 151. Europe Patent Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Patent Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 153. Asia Pacific Patent Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Patent Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 155. South America Patent Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Patent Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Patent Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Patent Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 159. Global Patent Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Patent Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 161. Global Patent Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 162. Global Patent Drug Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Patent Drug Market Size Comparison by Region (M USD)
Table 5. Global Patent Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Patent Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Patent Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Patent Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Patent Drug as of 2022)
Table 10. Global Market Patent Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Patent Drug Sales Sites and Area Served
Table 12. Manufacturers Patent Drug Product Type
Table 13. Global Patent Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Patent Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Patent Drug Market Challenges
Table 22. Global Patent Drug Sales by Type (Kilotons)
Table 23. Global Patent Drug Market Size by Type (M USD)
Table 24. Global Patent Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Patent Drug Sales Market Share by Type (2019-2024)
Table 26. Global Patent Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Patent Drug Market Size Share by Type (2019-2024)
Table 28. Global Patent Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Patent Drug Sales (Kilotons) by Application
Table 30. Global Patent Drug Market Size by Application
Table 31. Global Patent Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Patent Drug Sales Market Share by Application (2019-2024)
Table 33. Global Patent Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Patent Drug Market Share by Application (2019-2024)
Table 35. Global Patent Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Patent Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Patent Drug Sales Market Share by Region (2019-2024)
Table 38. North America Patent Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Patent Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Patent Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Patent Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Patent Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Patent Drug Basic Information
Table 44. Pfizer Patent Drug Product Overview
Table 45. Pfizer Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Patent Drug SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. Roche Patent Drug Basic Information
Table 50. Roche Patent Drug Product Overview
Table 51. Roche Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Roche Business Overview
Table 53. Roche Patent Drug SWOT Analysis
Table 54. Roche Recent Developments
Table 55. Sanofi Patent Drug Basic Information
Table 56. Sanofi Patent Drug Product Overview
Table 57. Sanofi Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Patent Drug SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Johnson and Johnson Patent Drug Basic Information
Table 62. Johnson and Johnson Patent Drug Product Overview
Table 63. Johnson and Johnson Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Johnson and Johnson Business Overview
Table 65. Johnson and Johnson Recent Developments
Table 66. Merck and Co. (MSD) Patent Drug Basic Information
Table 67. Merck and Co. (MSD) Patent Drug Product Overview
Table 68. Merck and Co. (MSD) Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Merck and Co. (MSD) Business Overview
Table 70. Merck and Co. (MSD) Recent Developments
Table 71. Novartis Patent Drug Basic Information
Table 72. Novartis Patent Drug Product Overview
Table 73. Novartis Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Novartis Business Overview
Table 75. Novartis Recent Developments
Table 76. AbbVie Patent Drug Basic Information
Table 77. AbbVie Patent Drug Product Overview
Table 78. AbbVie Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. AbbVie Business Overview
Table 80. AbbVie Recent Developments
Table 81. Gilead Sciences Patent Drug Basic Information
Table 82. Gilead Sciences Patent Drug Product Overview
Table 83. Gilead Sciences Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Gilead Sciences Business Overview
Table 85. Gilead Sciences Recent Developments
Table 86. GlaxoSmithKline (GSK) Patent Drug Basic Information
Table 87. GlaxoSmithKline (GSK) Patent Drug Product Overview
Table 88. GlaxoSmithKline (GSK) Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. GlaxoSmithKline (GSK) Business Overview
Table 90. GlaxoSmithKline (GSK) Recent Developments
Table 91. Amgen Patent Drug Basic Information
Table 92. Amgen Patent Drug Product Overview
Table 93. Amgen Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Amgen Business Overview
Table 95. Amgen Recent Developments
Table 96. AstraZeneca Patent Drug Basic Information
Table 97. AstraZeneca Patent Drug Product Overview
Table 98. AstraZeneca Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. AstraZeneca Business Overview
Table 100. AstraZeneca Recent Developments
Table 101. Bristol-Myers Squibb Patent Drug Basic Information
Table 102. Bristol-Myers Squibb Patent Drug Product Overview
Table 103. Bristol-Myers Squibb Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Bristol-Myers Squibb Business Overview
Table 105. Bristol-Myers Squibb Recent Developments
Table 106. Eli Lilly Patent Drug Basic Information
Table 107. Eli Lilly Patent Drug Product Overview
Table 108. Eli Lilly Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Eli Lilly Business Overview
Table 110. Eli Lilly Recent Developments
Table 111. Teva Patent Drug Basic Information
Table 112. Teva Patent Drug Product Overview
Table 113. Teva Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Teva Business Overview
Table 115. Teva Recent Developments
Table 116. Bayer Patent Drug Basic Information
Table 117. Bayer Patent Drug Product Overview
Table 118. Bayer Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Bayer Business Overview
Table 120. Bayer Recent Developments
Table 121. Novo Nordisk Patent Drug Basic Information
Table 122. Novo Nordisk Patent Drug Product Overview
Table 123. Novo Nordisk Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 124. Novo Nordisk Business Overview
Table 125. Novo Nordisk Recent Developments
Table 126. AbbVie Patent Drug Basic Information
Table 127. AbbVie Patent Drug Product Overview
Table 128. AbbVie Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 129. AbbVie Business Overview
Table 130. AbbVie Recent Developments
Table 131. Takeda Patent Drug Basic Information
Table 132. Takeda Patent Drug Product Overview
Table 133. Takeda Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 134. Takeda Business Overview
Table 135. Takeda Recent Developments
Table 136. Boehringer Ingelheim Patent Drug Basic Information
Table 137. Boehringer Ingelheim Patent Drug Product Overview
Table 138. Boehringer Ingelheim Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 139. Boehringer Ingelheim Business Overview
Table 140. Boehringer Ingelheim Recent Developments
Table 141. Takeda Patent Drug Basic Information
Table 142. Takeda Patent Drug Product Overview
Table 143. Takeda Patent Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 144. Takeda Business Overview
Table 145. Takeda Recent Developments
Table 146. Global Patent Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 147. Global Patent Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 148. North America Patent Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 149. North America Patent Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 150. Europe Patent Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 151. Europe Patent Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 152. Asia Pacific Patent Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 153. Asia Pacific Patent Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 154. South America Patent Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 155. South America Patent Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 156. Middle East and Africa Patent Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 157. Middle East and Africa Patent Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 158. Global Patent Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 159. Global Patent Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 160. Global Patent Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 161. Global Patent Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 162. Global Patent Drug Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Patent Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Patent Drug Market Size (M USD), 2019-2030
Figure 5. Global Patent Drug Market Size (M USD) (2019-2030)
Figure 6. Global Patent Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Patent Drug Market Size by Country (M USD)
Figure 11. Patent Drug Sales Share by Manufacturers in 2023
Figure 12. Global Patent Drug Revenue Share by Manufacturers in 2023
Figure 13. Patent Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Patent Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Patent Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Patent Drug Market Share by Type
Figure 18. Sales Market Share of Patent Drug by Type (2019-2024)
Figure 19. Sales Market Share of Patent Drug by Type in 2023
Figure 20. Market Size Share of Patent Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Patent Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Patent Drug Market Share by Application
Figure 24. Global Patent Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Patent Drug Sales Market Share by Application in 2023
Figure 26. Global Patent Drug Market Share by Application (2019-2024)
Figure 27. Global Patent Drug Market Share by Application in 2023
Figure 28. Global Patent Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Patent Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Patent Drug Sales Market Share by Country in 2023
Figure 32. U.S. Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Patent Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Patent Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Patent Drug Sales Market Share by Country in 2023
Figure 37. Germany Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Patent Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Patent Drug Sales Market Share by Region in 2023
Figure 44. China Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Patent Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Patent Drug Sales Market Share by Country in 2023
Figure 51. Brazil Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Patent Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Patent Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Patent Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Patent Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Patent Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Patent Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Patent Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Patent Drug Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Patent Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Patent Drug Market Size (M USD), 2019-2030
Figure 5. Global Patent Drug Market Size (M USD) (2019-2030)
Figure 6. Global Patent Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Patent Drug Market Size by Country (M USD)
Figure 11. Patent Drug Sales Share by Manufacturers in 2023
Figure 12. Global Patent Drug Revenue Share by Manufacturers in 2023
Figure 13. Patent Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Patent Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Patent Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Patent Drug Market Share by Type
Figure 18. Sales Market Share of Patent Drug by Type (2019-2024)
Figure 19. Sales Market Share of Patent Drug by Type in 2023
Figure 20. Market Size Share of Patent Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Patent Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Patent Drug Market Share by Application
Figure 24. Global Patent Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Patent Drug Sales Market Share by Application in 2023
Figure 26. Global Patent Drug Market Share by Application (2019-2024)
Figure 27. Global Patent Drug Market Share by Application in 2023
Figure 28. Global Patent Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Patent Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Patent Drug Sales Market Share by Country in 2023
Figure 32. U.S. Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Patent Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Patent Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Patent Drug Sales Market Share by Country in 2023
Figure 37. Germany Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Patent Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Patent Drug Sales Market Share by Region in 2023
Figure 44. China Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Patent Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Patent Drug Sales Market Share by Country in 2023
Figure 51. Brazil Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Patent Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Patent Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Patent Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Patent Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Patent Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Patent Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Patent Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Patent Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Patent Drug Market Share Forecast by Application (2025-2030)
